Fig. 1From: RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNAHuntingtin mutation and basal ganglia. Huntington’s results from an expanded polyglutamine tract, encoded by CAG repeats. The basal ganglia is the most severely affected region in HDBack to article page